Zou JP - Search Results

1

Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.

Shimizu J, Zou JP, Ikegame K, Katagiri T, Fujiwara H, Hamaoka T. Shimizu J, et al. Among authors: zou jp. J Immunol. 1991 Mar 1;146(5):1708-14. J Immunol. 1991. PMID: 1993850

2

Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.

Zou JP, Shimizu J, Ikegame K, Yamamoto N, Ono S, Fujiwara H, Hamaoka T. Zou JP, et al. J Immunol. 1992 Jan 15;148(2):648-55. J Immunol. 1992. PMID: 1345922

3

Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells.

Zou JP, Shimizu J, Ikegame K, Takiuchi H, Fujiwara H, Hamaoka T. Zou JP, et al. Cancer Immunol Immunother. 1992;35(1):1-6. doi: 10.1007/BF01741047. Cancer Immunol Immunother. 1992. PMID: 1611618 Free PMC article.

4

Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unit.

Shimizu J, Zou JP, Ikegame K, Fujiwara H, Hamaoka T. Shimizu J, et al. Among authors: zou jp. Jpn J Cancer Res. 1991 Mar;82(3):262-5. doi: 10.1111/j.1349-7006.1991.tb01840.x. Jpn J Cancer Res. 1991. PMID: 1902448 Free PMC article.

5

Suppression of anti-tumor CD4+ T cell responsiveness in the tumor-bearing state and its recovery in in vitro culture free of tumor burden.

Nagata T, Zou JP, Yamamoto N, Ono S, Fujiwara H, Hamaoka T. Nagata T, et al. Among authors: zou jp. Jpn J Cancer Res. 1993 Nov;84(11):1181-9. doi: 10.1111/j.1349-7006.1993.tb02819.x. Jpn J Cancer Res. 1993. PMID: 7903964 Free PMC article.

6

Recovery of antitumor CD4+ T cell responsiveness, suppressed in the tumor-bearing state, by release from tumor burden.

Zou JP, Nagata T, Yamamoto N, Ono S, Fujiwara H, Hamaoka T. Zou JP, et al. J Cancer Res Clin Oncol. 1994;120(5):279-85. doi: 10.1007/BF01236384. J Cancer Res Clin Oncol. 1994. PMID: 7907334

7

Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function.

Li XF, Takiuchi H, Zou JP, Katagiri T, Yamamoto N, Nagata T, Ono S, Fujiwara H, Hamaoka T. Li XF, et al. Among authors: zou jp. Jpn J Cancer Res. 1993 Mar;84(3):315-25. doi: 10.1111/j.1349-7006.1993.tb02873.x. Jpn J Cancer Res. 1993. PMID: 8098027 Free PMC article.

8

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.

Zou JP, Yamamoto N, Fujii T, Takenaka H, Kobayashi M, Herrmann SH, Wolf SF, Fujiwara H, Hamaoka T. Zou JP, et al. Int Immunol. 1995 Jul;7(7):1135-45. doi: 10.1093/intimm/7.7.1135. Int Immunol. 1995. PMID: 8527411

9

Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12.

Yu WG, Yamamoto N, Takenaka H, Mu J, Tai XG, Zou JP, Ogawa M, Tsutsui T, Wijesuriya R, Yoshida R, Herrmann S, Fujiwara H, Hamaoka T. Yu WG, et al. Among authors: zou jp. Int Immunol. 1996 Jun;8(6):855-65. doi: 10.1093/intimm/8.6.855. Int Immunol. 1996. PMID: 8671675

10

Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12.

Ogawa M, Tsutsui T, Zou JP, Mu J, Wijesuriya R, Yu WG, Herrmann S, Kubo T, Fujiwara H, Hamaoka T. Ogawa M, et al. Among authors: zou jp. Cancer Res. 1997 Jun 1;57(11):2216-22. Cancer Res. 1997. PMID: 9187124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters